BIOMAT Database Logo BIOMAT Database Logo

Intranasal calcitonin for prevention and treatment of osteoporosis. 1988

C Christiansen
Department of Clinical Chemistry, Glostrup Hospital, Denmark.

Age-related diseases constitute an ever increasing problem in an ageing population. The objectives of future medical research in this field should not only seek to increase longevity, but also to improve the quality of life of the elderly and to enable them to live independently for a longer period of time. Osteoporosis is a prime example of such a disease, because we have the tool to prevent it, i.e. oestrogen and calcitonin, and because in all probability it will some day be curable.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations

Related Publications

C Christiansen
Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis.
July 1996, Calcified tissue international,
C Christiansen
Calcitonin for prevention and treatment of osteoporosis.
November 1993, The American journal of medicine,
C Christiansen
Calcitonin for prevention and treatment of postmenopausal osteoporosis.
September 1995, Clinical rheumatology,
C Christiansen
[Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
April 2005, Georgian medical news,
C Christiansen
Postmenopausal osteoporosis: prevention and treatment with calcitonin.
June 1992, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
C Christiansen
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
May 2000, The Journal of clinical endocrinology and metabolism,
C Christiansen
Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.
January 2000, The Cochrane database of systematic reviews,
C Christiansen
[Calcitonin in the treatment and prevention of osteoporosis].
May 1994, Revue medicale de Liege,
C Christiansen
Calcitonin in the prevention and treatment of osteoporosis.
January 1993, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
C Christiansen
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
May 2002, Bone,
Copied contents to your clipboard!